US10159679B2ActiveUtilityA1

Metal delivery agents and therapeutic uses of the same

Assignee: UNIV MELBOURNEPriority: Nov 20, 2006Filed: Dec 16, 2014Granted: Dec 25, 2018
Est. expiryNov 20, 2026(~0.3 yrs left)· nominal 20-yr term from priority
A61P 9/00A61P 9/10A61P 35/00A61P 33/06A61P 31/00A61P 27/12A61P 27/06A61P 27/02A61P 25/28A61P 25/18A61P 25/16A61P 25/14A61P 25/08A61P 25/00C07F 3/06A61P 1/00A61K 31/555A61K 31/28A61K 31/315A61K 31/145A61K 31/30C07F 1/08
53
PatentIndex Score
0
Cited by
45
References
20
Claims

Abstract

The present invention relates to metal complexes, processes for their preparation and their use as pharmaceutical or veterinary agents, in particular for the treatment of conditions in which metal delivery can prevent, alleviate or ameliorate the condition. There are a number of clinical conditions which are caused by or associated with abnormal levels of metals (typically low metal levels). Conditions in of this type include cancer and conditions characterized by or associated with oxidative damage, more specifically neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease or Huntington's disease. The invention also relates to ligands useful in the preparation of metal complexes of this type.

Claims

exact text as granted — not AI-modified
The claims defining the invention are as follows: 
     
       1. A method comprising
 providing a subject suffering from a disease selected from the group consisting of Parkinson's disease and amyotrophic lateral sclerosis; and 
 administering to the subject a therapeutically effective amount of a complex of Formula (I): 
 
       
         
           
           
               
               
           
         
         where: 
         the complex is symmetrical; 
         M is Cu or Zn; 
         R 1  and R 5  are each hydrogen; 
         R 2  and R 6  are each methyl, ethyl, or phenyl; and 
         R 3  and R 4  are each methyl. 
       
     
     
       2. The method of  claim 1  where the disease is Parkinson's disease. 
     
     
       3. The method of  claim 1  where the disease is amyotrophic lateral sclerosis. 
     
     
       4. The method of  claim 1  where M is Cu. 
     
     
       5. The method of  claim 1  where M is Zn. 
     
     
       6. The method of  claim 1  where R2 and R6 are each methyl. 
     
     
       7. The method of  claim 1  where R2 and R6 are each ethyl. 
     
     
       8. The method of  claim 1  where R2 and R6 are each phenyl. 
     
     
       9. The method of  claim 2  where M is Cu and R2 and R6 are each methyl. 
     
     
       10. The method of  claim 2  where M is Cu and R2 and R6 are each ethyl. 
     
     
       11. The method of  claim 2  where M is Cu and R2 and R6 are each phenyl. 
     
     
       12. The method of  claim 2  where M is Zn and R2 and R6 are each methyl. 
     
     
       13. The method of  claim 2  where M is Zn and R2 and R6 are each ethyl. 
     
     
       14. The method of  claim 2  where M is Zn and R2 and R6 are each phenyl. 
     
     
       15. The method of  claim 3  where M is Cu and R2 and R6 are each methyl. 
     
     
       16. The method of  claim 3  where M is Cu and R2 and R6 are each ethyl. 
     
     
       17. The method of  claim 3  where M is Cu and R2 and R6 are each phenyl. 
     
     
       18. The method of  claim 3  where M is Zn and R2 and R6 are each methyl. 
     
     
       19. The method of  claim 3  where M is Zn and R2 and R6 are each ethyl. 
     
     
       20. The method of  claim 3  where M is Zn and R2 and R6 are each phenyl.

Join the waitlist — get patent alerts

Track US10159679B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.